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(57) ABSTRACT
The invention pertains to methods of altering growth, lignin 
content, coniferyl and sinapyl alcohol units in the lignin 
structure, disease resistance and cellulose content in plants 
by transformation with a lignin pathway p-coumarate 
Co-enzyme A ligase (4CL) nucleic acid.
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METHODS OF MODIFYING FIGNIN IN 
PLANTS BY TRANSFORMATION WITH A 4- 
COUMARATE COENZYME A LIGASE 
NUCLEIC ACID
STATEMENT OF GOVERNMENT RIGHTS
The present invention was made at least in part with the 
support of the United States Government via a grant from 
the U.S. Department of Agriculture (Grant No. 95-37103- 
2061). The Government may have certain rights in the 
invention.
FIELD OF THE INVENTION
The invention relates to genetically modifying trees 
through manipulation of the lignin biosynthesis pathway, 
and more particularly, to genetically modifying trees 
through the down regulation of p-coumarate Co-enzyme A 
ligase (CCL) to achieve faster growth, and/or altered lignin 
content, and/or altered lignin structure, and/or altered cel­
lulose content and/or disease resistance of the trees and to 
the use of promoters of the CCL genes to drive gene 
expression specifically in xylem tissue or specifically in 
epidermal tissues.
BACKGROUND OF THE INVENTION
Genetic engineering of forest tree species to conform to 
desired traits has shifted the emphasis in forest tree improve­
ment away from the traditional breeding programs during 
the past decade. Although research on genetic engineering of 
forest trees has been vigorous, the progress has been slow 
due.
The ability to make trees grow faster and be disease 
resistant to produce the highest volume of wood in the 
shortest period of time has been and continues to be the top 
objective of many forest products company worldwide. The 
ability to genetically increase the optimal growth of trees 
would be a commercially significant improvement. Faster 
growing trees could be used by all sectors of the forest and 
wood products industry worldwide.
Lignin, a complex phenolic polymer, is a major compo­
nent in cell walls of secondary xylem. In general, lignin 
constitutes 25% of the dry weight of the wood, making it the 
second most abundant organic compound on earth after 
cellulose. Although lignin plays an important role in plants, 
it usually represents an obstacle to utilizing biomass in 
several applications. For example, in woodpulp production, 
lignin has to be removed through expensive and polluting 
processes in order to recover cellulose.
Thus, it is desirable to genetically engineer plants with 
reduced lignin content and/or altered lignin composition that 
can be utilized more efficiently. Trees that could be geneti­
cally engineered with a reduced amount of lignin would be 
commercially valuable. These genetically engineered trees 
would be less expensive to pulp because, in essence, part of 
the pulping has already been performed due to the reduced 
amount of lignin.
Trees with increased cellulose content would also be 
commercially valuable to the pulp and paper industry.
Disease resistance in plants is also a most desirable plant 
trait. The impact of disease resistance in trees on the 
economy of forest products industry worldwide is signifi­
cant.
Promoters that target specific plant tissue could be useful 
in manipulating gene expression to enable the engineering of 
traits of interest in specific tissue of plants, such as, xylem 
and epidermal tissues.
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Although studies have revealed several general properties 
of plant p-coumarate Co-enzyme A ligase (CCL), the role of 
CCL in regulating the synthesis of monolignols in response 
to different states of development and environmental stress 
in tree species remains largely unknown. Furthermore, mul­
tiple CCL isoforms are normally present in plants, channel­
ing phenolic compounds to the biosynthesis of not only 
lignin but also other phenylpropanoids, such as flavonoids. 
Since CCL isoforms have not been previously cloned from 
tree species for the identification of their biochemical 
functions, the presence of CCL isoforms remains so far as a 
challenge to a specific control of metabolic flux to the lignin 
biosynthesis in tree species.
SUMMARY OF THE INVENTION
The invention provides a method to genetically alter trees 
through the down regulation of p-coumarate Co-enzyme A 
ligase (CCL). Such down regulation of CCL results in faster 
growth, and/or reduced lignin content, and/or altered lignin 
structure, and/or altered cellulose content and/or disease 
resistance. The invention also provides for genetically engi­
neered trees which have been altered to down regulate 
p-coumarate Co-enzyme A ligase (CCL) to achieve faster 
growth, and/or reduced lignin content, and/or altered lignin 
structure, and/or increased cellulose content and/or 
increased disease resistance. The invention also provides 
tissue specific promoters of the CCL genes that can be used 
to manipulate gene expression in target tissue such as xylem 
and epidermal tissues.
It is one object of the present invention to down regulate 
p-coumarate Co-enzyme A ligase (CCL) in trees.
It is another object of the present invention to provide a 
method to genetically alter trees to grow faster.
It is another object of the present invention to provide a 
method to genetically alter the growth of trees through 
manipulation the lignin pathway p-coumarate Co-enzyme A 
ligase.
It is another object of the present invention to provide 
genetically altered trees with an accelerated growth charac­
teristic.
It is another object of the present invention to provide 
transgenic trees with an accelerated growth characteristic 
which have been genetically altered by down regulating 
lignin pathway p-coumarate Co-enzyme A ligase.
It is another object of the present invention to provide a 
method to genetically alter trees to reduce their lignin 
content.
It is another object of the present invention to provide a 
method to genetically alter the lignin content of trees 
through manipulation of a lignin pathway enzyme.
It is another object of the present invention to genetically 
engineer trees which have reduced lignin content through 
manipulation of lignin pathway p-coumarate Co-enzyme A 
ligase.
It is another object of the present invention to provide 
genetically altered trees with a reduced lignin content.
It is another object of the present invention to provide 
transgenic trees with reduced lignin content which have 
been genetically altered by down regulating the p-coumarate 
Co-enzyme A ligase (CCL).
It is another object of the present invention to provide a 
method to genetically alter trees to change their lignin 
structure through manipulation of lignin pathway 
p-coumarate Co-enzyme A ligase.
It is another object of the present invention to provide 
trees with altered lignin structure.
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It is another object of the present invention to provide a 
method to increase the cellulose content in trees.
It is another object of the present invention to provide a 
method to increase the cellulose content of trees through the 
manipulation of a lignin pathway enzyme.
It is another object of the present invention to provide 
trees with increased cellulose content.
It is another object of the present invention to provide 
transgenic trees having increased cellulose content from the 
down regulation of CCL.
It is another object of the present invention to provide a 
method to genetically alter trees to increase their disease 
resistance.
It is another object of the present invention to provide a 
method to genetically alter trees to be more disease resistant 
through manipulation of the lignin pathway p-coumarate 
Co-enzyme A ligase.
It is another object of the present invention to genetically 
alter trees to increase their disease resistance to fungal 
pathogens.
It is another object of the present invention to provide 
trees with increased disease resistance.
It is another object of the present invention to provide 
transgenic trees with increased disease resistance through 
down regulation of the lignin pathway p-coumarate 
Co-enzyme A ligase.
It is another object of the present invention to provide a 
method using a promoter of a CCL gene to target gene 
expression in specific plant tissue.
It is another object of the present invention to provide a 
method using a promoter of a CCL gene to target gene 
expression specifically in plant xylem.
It is another object of the present invention to provide a 
method using a promoter of the CCL gene to target gene 
expression specifically in the epidermal tissues of plants.
It is another object of the present invention to provide a 
CCL gene promoter that targets gene expression specifically 
in the xylem of plants.
It is another object of the present invention to provide a 
CCL gene promoter that targets gene expression specifically 
in the epidermal tissues of plants.
Other features and advantages of the invention will 
become apparent to those of ordinary skill in the art upon 
review of the following drawing, detailed description and 
claims.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic of a phenylpropanoid pathway;
FIG. 2 is a diagram of Agrobacterium T-DNA construct 
pACCLl;
FIG. 3 is a restriction map of genomic clone PtCCLlg-4;
FIG. 4 is a restriction map of genomic clone PtCCL2g-ll;
FIG. 5 is a restriction map of subcloned PtCCLl gene 
promoter p7Z-4XS;
FIG. 6 is a restriction map of subcloned PtCCL2 gene 
promoter pSK-llHE
FIG. 7 is an Agrobacterium T-DNA construct of PtCCLl 
promoter and GUS fusion gene, PtCCLlp-GUS; and
FIG. 8 is an Agrobacterium T-DNA construct of PtCCL2 
promoter and GUS fusion gene, PtCCL2p-GUS.
Before one embodiment of the invention is explained in 
detail, it is to be understood that the invention is not limited 
in its application to the details set forth in the following
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description of the preferred embodiment. The invention is 
capable of other embodiments and of being practiced or 
being carried out in various ways. Also, it is to be understood 
that the phraseology and terminology used herein is for the 
purpose of description and should not be regarded as lim­
iting.
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENT
The invention pertains to genetically down regulating a 
lignin pathway p-coumarate Co-enzyme A ligase (CCL). 
Trees which have been genetically transformed to down 
regulate CCL will hereafter be called transgenic trees. Such 
down regulation can result in faster growing trees. Such 
down regulation can result in a reduction in the lignin 
content of the trees and/or altered lignin structure. Such 
down regulation can result in increased cellulose content. 
Such down regulation can result in increased tree disease 
resistance. Further, by using a specific promoter of CCL, 
targeted tissue gene expression can be achieved in either the 
xylem or the epidermal tissues of the plant.
A. CCL
Lignin is synthesized by the oxidative coupling of three 
monolignols (coumaryl, coniferyl and sinapyl alcohols) 
formed via the phenylpropanoid pathway as shown in FIG. 
1. Reactions in the phenylpropanoid pathway include the 
deamination of phenylalanine to cinnamic acid followed by 
hydroxylations, methylations and activation of substituted 
cinnamic acids to coenzyme A (CoA) esters. The CoA esters 
are then reduced to form monolignols which are secreted 
from cells to form lignin.
The products of the phenylpropanoid pathway are not 
only required for the synthesis of lignin but also required for 
the synthesis of a wide range of aromatic compounds 
including flavonoids, phytoalexins, stilbenes and suberin.
In angiosperms (hardwoods), lignin is composed of both 
coniferyl and sinapyl alcohol and is classified as guaiacyl- 
syringyl lignin. Grasses synthesize a third precursor 
(p-coumaryl alcohol) which is polymerized along with 
coniferyl and sinapyl alcohol. In gymnosperms (softwoods), 
lignin is composed of mainly coniferyl alcohol and is 
classified as guaiacyl lignin.
In the phenylpropanoid pathway, CCL activates a number 
of cinnamic acid derivatives, including p-courmaric acid, 
caffeic acid, ferulic acid, 5-hydroxyferulic acid and sinapic 
acid. The resulting products, CoA esters, serve as substrates 
for entry into various branch pathways, such as lignin, 
flavonoids, phytoalexins, stilbenes and suberin. The esteri­
fication reactions catalyzed by CCL require high energy and 
the reactions are not likely to occur without CCL. CCL is 
important in making a continuous flow of the lignin biosyn­
thesis pathway. CCL is also important because it is located 
at the branching points of the phenylpropanoid metabolism. 
CCL is suggested to play a pivotal role in regulating carbon 
flow into specific branch pathways of the phenylpropanoid 
metabolism in response to stages of development and envi­
ronmental stress.
The basic properties of CCL are quite uniform. CCL 
depends on ATP as a cosubstrate and requires Mg2+ as a 
cofactor. The optimal pH for CCL ranges from pH 7.0 to 8.5 
and the molecular weight of CCL isoforms from various 
plant species ranges from 40 kd to 75 kd. Most CCLs have 
high affinity with substituted cinnamic acids. CCL has the 
highest activity with p-coumaric acid.
CCL cDNA sequences have been reported for parsley, 
potato, soybean, loblolly pine, Arabidopsis, Lithosperum
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and tobacco. CCL genes have been isolated and sequenced 
for parsley, rice, potato and loblolly pine. The analysis of 
CCL cDNAs and genes indicates that CCL is encoded by 
multiple/divergent genes in rice, soybean, and Lithosperum, 
very similar genes in parsley, potato, tobacco and loblolly 
pine, and a single gene in Arabidopsis. CCL promoters have 
been isolated and sequenced for parsley, rice and potato.
Alignment of deduced amino acid sequences of cloned 
plant CCL sequences reveals two highly conserved regions. 
The first conserved region (SSGTTGLPKGV)(SEQ ID 
NO:7), proposed to designate a putative AMP-binding 
region, is very rich in Gly, Ser and Thr and is followed by 
a conserved Lys. The second conserved region (GEICIRG) 
(SEQ ID NO:8) contains one common Cys residue. The 
amino acid sequences of CCL from plants contain a total of 
five conserved Cys residues.
The CCL genes of parsley, potato and rice contain five 
exons and four introns. The CCL genes also share the same 
exon/intron splice junction sites but have different lengths of 
introns. The genomic sequences of loblolly pine CCL are 
composed of four exons and three introns. It has been found 
that two similar CCL genes of the same species may differ 
slightly in length of intron as shown in two parsley genes 
(PC4CL1 and PC4CL2) and in two loblolly pine genes 
(LP4CL1 and LP4CL2).
By Northern blot analysis, it has been shown that CCL is 
expressed in leaf, shoot tip, stem, root, flower and cell 
culture. Two similar CCL cDNAs in parsley, potato and 
tobacco have been shown to be expressed at similar level in 
response to the environmental stress and during different 
developmental stages. Two distinct CCL cDNAs in soybean 
and Lithosperum have shown different expression levels 
when pathogens or chemicals were applied to the cell 
cultures. It appears that the expression of the CCL genes is 
developmentally regulated and inducible by many environ­
mental stresses at the transcription level.
Genetic transformation with a CCL sequence can result in 
several significant affects. The description of the invention 
hereafter refers to aspen, and in particular quaking aspen 
(Populus tremuloides Michx) when necessary for the sake of 
example. Elowever, it should be noted that the invention is 
not limited to genetic transformation of aspen. The method 
of the present invention is capable of being practiced for 
other trees, including for example, other angiosperms, other 
gymnosperm forest tree species, etc.
Preferably, the CCL down regulation is accomplished 
through transformation with a homologous CCL sequence in 
an antisense orientation. However, it should be noted that a 
heterologous antisense CCL sequence could be utilized and 
incorporated into a tree species to down regulate CCL if the 
heterologous CCL gene sequence has a high nucleotide 
sequence homology, approximately higher than 70%, to the 
endogenous CCL gene sequence of that tree species.
In addition, trees transformed with a sense CCL sequence 
could also cause a sequence homology-based cosuppression 
of the expression of the transgene and endogenous CCL 
gene, thereby achieving down regulation of CCL in these 
trees.
B. Isolation of CCL cDNAs
The present invention utilizes a homologous CCL 
sequence to genetically alter trees. The preferred embodi­
ment of the invention as further described below utilizes a 
cDNA clone of the quaking aspen CCL gene.
Two aspen (Populus tremuloides Michx) cDNAs encod­
ing two distinct CCL isoforms, PtCCLland PtCCL2 have
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been cloned. PtCCLl cDNA is lignin pathway-specific and 
is different from PtCCL2 cDNA, which is involved in 
flavonoid synthesis. The cloning of PtCCLl and PtCCL2 
cDNAs and the identification of their biochemical functions 
will be discussed in more length below. PtCCLl and 
PtCCL2 genomic clones including their 5'-end regulatory 
promoter sequences were also isolated. The promoter of 
PtCCLl (PtCCLlp) directs xylem tissue-specific gene 
expression in a plant, whereas the promoter of PtCCL2 
(PtCCL2p) drives the expression of genes specifically in 
epidermal tissues of stem and leaf of a plant. These tissue 
specific promoters will be discussed in more length in 
Section I below.
Two CCL cDNAs, PtCCLl and PtCCL2, have been 
isolated from quaking aspen using either a conventional 
cDNA library screening method or a PCR-based cDNA 
cloning method. It should be noted that the methods 
described below are set forth as an example and should not 
be considered limiting. These CCL cDNA clones are avail­
able from Michigan Technological University, Institute of 
Wood Research, Houghton, Mich.
Young leaves and shoot tips are collected from 
greenhouse-grown quaking aspen (Populus tremuloides 
Michx). Differentiating xylem and sclerenchyma are col­
lected from three to four year old quaking aspen. The bark 
is peeled from the tree exposing the developing secondary 
xylem on the woody stem and the sclerenchyma on the inner 
side of the bark. Developing secondary xylem and scleren­
chyma are scraped from the stem and bark with a razor blade 
and immediately frozen in liquid nitrogen until use.
Total RNA is isolated from the young leaves, shoot tips, 
xylem and sclerenchyma following the method of Bugos RC 
et al. (1995), RNA Isolation from Plant Tissue Recalcitrant 
to Extraction in Guanidine, Biotechniques 19(5):734-737. 
Poly(A)+RNA is purified from total RNA using Poly(A)+ 
mRNA Isolation Kit from Tel-test B. Inc. A unidirectional 
Lambda gt22 expression cDNA library was constructed 
from the xylem mRNA using Superscript X System from 
Life Technologies, Inc. and Gigapack Packaging Extracts 
from Stratagene. The PtCCLl cDNA was obtained by 
screening the cDNA library with a 32P-labeled parsley 4CL 
cDNA probe. The parsley 4CL cDNA (pc4CL2) has Gen- 
bank accession number X13325(SEQ ID NO:15).
The PtCCL2 cDNA was obtained by RT-PCR. The 
reverse transcription of total RNA isolated from shoot tips 
was carried our using the Superscript II reverse transcriptase 
from Life Technologies. Two sense primers (R1S, 
5'-TTGGATCCGGIACIACIGGIYTICCIAARGG-3'(SEQ 
ID N O :9) and H I S ,
5'-TTGGATCCGTIGCICARCARGTIGAYGG-3')(SEQ ID 
NO:10) are designed around the first consensus AMP- 
binding region of CCL that was previously discussed. One 
a n t i s e n s e  p r i m e r  (R2A,
S'-ATGTCGACCICGDATRCADATYTCICC-S'XSEQ ID 
NO:ll) is designed based on the sequence of the putative 
catalytic motif GEICIRG(SEQ ID NO:8). One fifth of the 
reverse transcription reaction (4 pi) is used as the template 
in a 50 pi PCR reaction containing lx  reaction buffer, 200 
pM each deoxyribonucleotide triphosphate, 2 pM each R1S 
and oligo-dT (20 mer) primers, and 2.5 units of Taq DNA 
polymerase. The PCR reaction mixture was denatured at 94°
C. for 5 minutes followed by 30 cycles of 94° C./45 seconds, 
50° C./l minute, 72° C./90 seconds and is ended with a 5 
minute extension at 72° C. 2 pi of the PCR amplification 
products are used for a second run PCR re-amplification 
using primers HIS and R2A. A 0.6 kb PCR fragment is 
cloned using the TA Cloning Kit from Invitrogen and used
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as a probe to screen an aspen genomic library to obtain the 
P tCC L2  geno m ic  c lone.  Two p r im er s  (2A,  
5'-TCTGTCTAGATGATGTCGTGGCCACGG-3'(SEQ ID 
NO : 12) and 2B,
S'-TTAGATCTCTAGGACATGGTGGTGGC-S'XSEQ ID 
NO: 13) are designed based on the genomic sequence of 
PtCCL2 at around the deduced transcription start site and 
stop codon for the cloning of PtCCL2 cDNA by RT-PCR as 
described above using total RNA isolated from shoot tips.
The DNA sequences of PtCCLland PtCCL2 cDNA were 
determined using ATaq Cycle Sequencing Kit from Amer- 
sham.
The PtCCLl cDNAhas an open reading frame of 1620 bp 
which encodes a polypeptide of 540 amino acid residues 
with a predicted molecular weight of 59 kd and pi of 5.8. 
The nucleotide sequence of the aspen CCL cDNA clone 
PtCCLl is set forth as SEQ ID NO:l. The deduced amono 
acid sequence for the aspen CCL1 protein is set forth as SEQ 
ID NO:2.
The PtCCL2 cDNAhas an open reading frame of 1713 bp 
which encodes a polypeptide of 571 amino acid residues 
with a predicted molecular weight of 61.8 kd and pi of 5.1. 
The nucleotide sequence of the aspen CCL cDNA clone 
PtCCL2 is set forth as SEQ ID NO:3. The deduced amino 
acid sequence for the aspen CCL2 protein is set forth as SEQ 
ID NO:4.
The aspen PtCCLl cDNA shares a 59-74% identity at the 
nucleotide level and 59-81% identity at the amino acid level 
with other prior reported CCL cDNAs and genes, whereas 
the PtCCL2 cDNA shares a 60-73% identity at the nucle­
otide level and 57-74% at the amino acid level with other 
CCL cDNAs and genes as set forth in the following table.
TABLE 1
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Comparison of PtCCLl and PtCCL2 Nucleotide 
and Predicted Amino Acid Sequence to Each 
_______Other and Other CCL Sequences_______
cDNA*
DNA
IDENTITY
%
PtCCLl
DNA
IDENTITY % 
PtCCL2
AMINO ACID 
IDENTITY % 
PtCCLl
AMINO
ACID
IDENTITY
% PtCCL2
PtCCLl 62 63
LE4CL1 69 62 71 64
LE4CL2 60 71 59 73
GM14 74 67 81 69
GM16 62 73 65 73
NT4CL1 67 62 75 74
NT4CL2 66 63 75 66
PC4CL1 66 64 71 64
PC4CL2 66 63 72 64
ST4CL1 67 63 75 64
AT4CL 66 63 70 61
LP4CL 61 64 63 67
OS4CL1 59 60 59 57
*PtCCLl: aspen CCL 
PtCCL2: aspen CCL
LE4CL1 and LE4CL2: Lithosperum erythrorhizon CCL
GM14 and GM16: soybean CCL
NT4CL1 and NT4CL2: tobacco CCL
PC4CL1 and PC4CL2: parsley CCL
ST4CL1: potato CCL
AT4CL: Arabidopsis CCL
LP4CL: loblolly pine CCL
OS4CL1: rice CCL
The results of sequence analysis, phylogenetic tree and 
genomic Southern blot analysis indicate that PtCCLl and 
PtCCL2 cDNAs encode two distinct CCLs that belong to 
two divergent gene families in aspen. The deduced amino 
acid sequence for the PtCCL2 protein contains a longer
N-terminal sequence than the PtCCLl protein but shows 
profound similarity in the central and C-terminal portions of 
protein to the PtCCLl protein.
PtCCLl and PtCCL2 cDNAs display distinct tissue- 
specific expression patterns. The PtCCLl sequence is 
expressed highly in the secondary developing xylem and in 
the 6th to 10th internodes whereas the PtCCL2 sequence is 
expressed in the shoot tip and leaves. These tissue-specific 
expression patterns were investigated by fusing promoters of 
PtCCLl and PtCCL2 genes to a GUS reporter gene. The 
tissue specific promoters for PtCCLl and PtCCL2 will be 
discussed in more length in Section I below.
The substrate specificity of PtCCLl and PtCCL2 is also 
different from each other as determined using recombinant 
proteins produced in E. coli. PtCCLl utilized p-coumaric 
acid, caffeic acid, ferulic acid and 5-hydroxyferulic acid as 
substrates. PtCCL2 showed activity to p-coumaric acid, 
caffeic acid and ferulic acid but not to 5-hydroxyferulic acid.
Specifically, PtCCll and PtCCL2 were used to construct 
expression vectors for E. coli expression. The substrate 
specificity of PtCCLl and PtCCL2 were tested using fusion 
proteins produced in E. coli. Two plasmids, pQE/CCLl and 
pQE/CCL2, were constructed in which the coding regions of 
PtCCLl and PtCCL2, respectively were fused to N-terminal 
His tags in expression plasmids pQE-31 and pQE-32 
(QIAGEN, Chatsworth, Calif). The recombinant proteins of 
PtCCLl and PtCCL2 produced by E. coli are approximately 
59 kd and 63 kd, respectively.
The two recombinant proteins were tested for their activ­
ity in utilizing cinnamic acid derivatives. PtCCLl recombi­
nant protein showed 100, 58, 71,18 and 0% relative activity 
to p-coumaric acid, caffeic acid, ferulic acid, 
5-hydroxyferulic acid and sinapic acid, respectively. 
PtCCL2 recombinant protein exhibited 100, 14, 27, 0 and 
0% relative activity to p-coumaric acid, caffeic acid, ferulic 
acid, 5-hydroxyferulic acid and sinapic acid, respectively. 
Neither recombinant protein showed detectable activity to 
sinapic acid.
The results of the tissue-specific expression pattern and 
substrate specificity suggests that in addition to the general 
function of CCL, PtCCLl apparently is more related to 
lignin synthesis in the xylem tissue and PtCCL2 apparently 
is more likely involved in flavonoid synthesis and UV 
protection.
It should be noted that the isolation and characterization 
of the PtCCLl and PtCCL2 cDNA clones is described in 
Kawaoka A, Chiang V L (1995), The Molecular Cloning and 
Expression of Syringyl- and Guaiacyl-Specific Hydroxycin- 
namate:CoA Ligases from Aspen (Populus tremuloides), 
Proceedings of the 6th International Conference on Biotech­
nology in the Pulp and Paper Industry, Vienna, Austria; and 
in Hu, Wen-Jing, Isolation and Characterization of 
p-coumarate Co-enzyme A ligase cDNAs and Genes from 
Quaking Aspen (Populous tremuloides Michx), Ph.D 
Dissertation, Michigan Technological University, Houghton, 
Mich. (1997); which are both herein incorporated by refer­
ence.
C. Transformation and Regeneration
Several methods for gene transformation of plant species 
with the CCL sequence are available such as the use of a 
transformation vector, agroinfection, electroinjection, par­
ticle bombardment with a gene gun or microinjection.
Preferably, a CCL cDNA clone is positioned in a binary 
expression vector in an antisense orientation under the 
control of double cauliflower mosiac virus 35S promoter.
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The vector is then preferably mobilized into a strain of 
Agrobacterium species such as tumefaciens strain C58/ 
pMP90 and is used as the DNA delivery system due to its 
efficiency and low cost.
For example, with reference to FIG. 2, the binary expres­
sion pACCLl used for plant transformations is shown. 
Specifically, the PtCCLl CDNA is inserted in an antisense 
orientation into Pac I and BamFl I sites between the double 
CaMV 35S/AMV RNA4 and the 3' terminator sequence of 
the nopaline synthase gene in a binary cloning vector 
pACCLl(FIG. 2). The binary vector containing hygromycin 
phosphotransferase (F1PT) gene is modified from pBin 19.
The gene construct pACCLlis available from Michigan 
Technological University, Institute of Wood Research, 
Floughton, Mich.
The binary vector construct is mobilized in Agrobacte­
rium tumefaciens using the freeze-thaw method of Flolsters 
et al., Mol. Gen. Genet. 163:181-187 (1978). For the 
freeze-thaw method, 1.5 ml of overnight cultures Agrobac­
terium tumefaciens strain C58/pMP90 is pelleted at 5000xg 
for 3 minutes at 4° C. and suspended in 1 ml of ice cold 20 
mM CaCl2. To the suspension is added 10 fA binary vector 
DNA (from an alkaline lysis minipreparation) and mixed by 
pipetting. The microcentrifuge tube is then frozen in liquid 
nitrogen for 5 minutes and thawed at 37° C. for 5 minutes. 
After being cooled on ice, 1 ml of LB is added and the 
mixture is incubated at 28° C. for 2 hours with gentle 
shaking. 200 pi of the cells is spread onto LB plates 
containing gentamycin and kanamycin and incubated at 28° 
C. for 2 days. Colonies grown on the selection plates are 
randomly picked or miniprep and restriction enzyme diges­
tion analysis is used to verify the integration.
The resulting binary vector containing Agrobacterium 
strain is used to transform quaking aspen according to Tsai 
et al., Agrobacterium-Mediated Transformation of Quaking 
Aspen (Populous tremuloides) and Regeneration of Trans­
genic Plants, Plant Cell Rep. 14:94—97 as set forth below.
Explants of young leaves from cuttings of aspen are 
obtained by cutting leaf disks of approximately 7 mm square 
from the young leaves along the midrib of the leaves. The 
explants are surface sterilized in 20% commercial bleach for 
10 minutes followed by rinsing 3 times with sterile double- 
distilled water.
All of the culture media used includes the basal medium 
of woody plant medium (WPM) as described in Lloyd et al., 
Proc. Int. Plant Prop. Soc. 30:421-437 (1980) and supple­
mented with 2% sucrose. 650 mg/L calcium gluconate and 
500 mg/L MES are added as pH buffers as described in Tsai, 
Plant Cell Reports, 1994. All culture media is adjusted to pH 
5.5 prior to the addition of 0.075% Difco Bacto Agar and 
then autoclaved at 121° C. and 15 psi for 20 minutes. Filter 
sterilized antibiotics are added to all culture media after 
autoclaving. All culture media are maintained at 23±1° C. in 
a growth chamber with 16 hour photoperiods 
(160 1irExm_2xS_1) except for callus induction (as will be 
described later) which is maintained in the dark.
The sterilized explants are then inoculated with the mobi­
lized vector with an overnight-grown agrobacterial suspen­
sion containing 20 fiM acetosyringone. After cocultivation 
for 2 days, the explants are washed in 1 mg/ml claforan and 
ticarcillin for 2 hours with shaking to kill Agrobacterium. 
The explants are blotted dry with sterile Whatman No. 1 
filter paper and transferred onto callus induction medium 
containing 50 mg/L kanamycin and 300 mg/L claforan to 
induce and select transformed callus. The callus induction 
medium is the basal medium with the addition of
9
6-benzyladenine (BA) and 2,4-dichlorophenoxyacetic acid 
(2,4-D) at concentrations of 0.5 mg/L and 1 mg/L, 
respectively, to induce callus.
The kanamycin-resistant explants are then subcultured on 
fresh callus induction media every two weeks. Callus for­
mation occurs after approximately four weeks. Formed 
callus are separated from the explant and subcultured peri­
odically for further proliferation.
When the callus clumps reach approximately 3 mm in 
diameter, the callus clumps are transferred to shoot regen­
eration medium. The shoot regeneration medium is the basal 
medium containing 50 mg/L kanamycin, 0.5 mg/L thidiazu- 
ron (TDZ) as a plant growth regulator and cefotaxime at 300 
mg/L to kill Agrobacterium. Shoots were regenerated about 
4 weeks after callus is transferred to regeneration medium.
As soon as the shoots are regenerated, they are immedi­
ately transferred to hormone-free elongation medium con­
taining 50 mg/L kanamycin and, whenever necessary, cefo­
taxime (300 mg/L), to promote elongation. Green and 
healthy shoots elongated to 2-3 cm in length are excised and 
planted separately in a hormone-free rooting medium con­
taining 50 mg/L kanamycin. The efficient uptake of kana­
mycin by shoots during their rooting stage provides the most 
effective selection for positive transformants. Transgenic 
plants are then transplanted into soil medium of vermicu- 
lite:peatmoss:perlite at 1:1:1 and grown in the greenhouse.
The above described transformation and regeneration 
protocol is readily adaptable to other tree species. Other 
published transformation and regeneration protocols for tree 
species include Danekar et al., Bio/Technology 5:587-590
(1987) ; McGranahan et al., Bio/Technology 6:800-804
(1988) ; McGranahan et al., Plant Cell Reports 8:512-616 
(1990); Chen, phD Thesis, North Carolina State University, 
Raleigh, N.C. (1991); Sullivan et al., Plant Cell Reports 
12:303-306 (1993); Huang et al., In Vitro Cell Dev. Bio. 
4:201-207 (1991); Wilde et al., Plant Physiol. 98:114-120 
(1992); Minocha et al., 1986 Proc. TAPPI Research and 
Development Conference, TAPPI Press, Atlanta, pp. 89-91 
(1986); Parsons et al., Bio/Technology 4:533-536 (1986); 
Fillatti et al., Mol. Gen. Genet 206:192-199 (1987); Pythoud 
et al., Bio/Technology 5:1323-1327 (1987); De Block, Plant 
Physiol. 93:1110-1116 (1990); Brasileiro et al., Plant Mol. 
Bio 17:441-452 (1991); Brasileiro et al., Transgenic Res. 
1:133-141 (1992); Howe et al., Woody Plant Biotech., 
Plenum Press, New York, pp.283-294 (1991); Klopfenstein 
et al., Can. J. For. Res. 21:1321-1328 (1991); Leple et al., 
Plant Cell Reports 11:137-141 (1992); and Nilsson et al. 
Transgenic Res. 1:209-220 (1992).
D. Phenotype Changes
The results of the transformation can be confirmed with 
conventional PCR and Southern analysis. For example, 
transferring CCL CDNA in an antisense orientation down 
regulates CCL in the tree. Expression of the CCL has been 
found to be blocked up to 96 percent in some transgenic 
trees.
After acclimation, the transgenic aspen display an unusual 
phenotype, including big curly leaves, thick diameters, 
longer internodes, more young leaves in the shoot tip and a 
red pigmentation in the petioles extending into midvein 
leaves. Red coloration of the developing secondary xylem 
tissues is observed after peeling of the bark in the transgenic 
plants.
E. Accelerated Growth
Down regulation of CCL alters growth of the transgenic 
trees. For example, transformation with an antisense CCL
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sequence accelerates the growth of the tree. Enhanced 
growth is markedly noticeable at all ages. In particular, the 
transgenic trees show enhanced growth in the form of 
thicker stems and enlarged leaves as compared to control 
trees. These characteristics are retained in the vegetative 
propagules of these transgenic trees. Table 2 sets forth 
exemplary data with respect to several lines of transgenic 
quaking aspen grown in the greenhouse after eight months. 
Volume represents the overall quantitative growth of the 
tree.
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TABLE 2
PLANT#
Growth Measurement for Control and Transgenic 
Plants
HEIGHT
(cm)
AVERAGE LENGTH
DIAMETER VOLUME OF INTERNODE 
(cm)* (cm3)* (cm)
Control 1 247.7 1.08 75.6 2.6
Control 2 250.2 1.01 66.8 2.8
11-1 304.8 1.15 105.5 3.1
11-2 248.9 1.01 66.4 3.4
11-3 241.3 0.84 44.6 3.2
11-4 288.3 0.94 66.7 3.4
11-5 246.4 0.92 54.6 3.3
11-7 226.7 1.13 75.7 3.4
11-8 289.6 1.16 102.0 3.3
11-9 287.0 1.76 232.6 4.3
11-10 252.7 0.83 45.6 3.1
11-11 247.7 0.86 48.0 3.5
12-1 247.7 1.1 78.4 2.7
12-2 199.4 0.96 48.1 2.5
12-6 294.6 0.92 65.2 3.2
16-1 227.3 0.95 53.7 2.8
16-2 278.1 0.97 68.5 3.4
16-3 265.4 1.09 82.5 3.5
17-2 243.8 0.89 50.5 2.6
*at 10 cm above ground
The averages for height, diameter, volume and average 
length between internodes for the control plants are as 
follows:
Height (cm) 248.95
Diameter (cm) 1.045
Volume (cm3) 71.2
Ave. Length of 2.7
Internodes (cm)
With respect to height alone, for those transgenic plants 
(11-1, 11-4, 11-8, 11-9, 12-6, 16-2, 16-3) having a statisti­
cally larger height than the control plants, the average height 
was 286.83 cm as compared to the control plant average 
height of 248.95 cm.
With respect to diameter alone, for those transgenic plants 
(11-1,11-7,11-8,11-9) having a statistically larger diameter 
than the control plants, the average diameter was 1.30 cm as 
compared to the control plant average diameter of 1.045 cm.
With respect to volume alone, for those transgenic plants 
(11-1, 11-8, 11-9, 12-1, 16-3) having a statistically larger 
volume than the control plants, the average volume was 
120.2 cm3 as compared to the control plant average volume 
of 71.2 cm3.
With respect to average length of internodes alone, for 
those transgenic plants (11-1, 11-2, 11-3, 11-4, 11-5, 11-7, 
11-8, 11-9, 11-10, 12-6, 16-2, 16-3) having a statistically 
larger average length of internodes than the control plants, 
the average average length of internodes was 3.39 cm as
compared to the control plant average average length of 
internodes of 2.7° cm.
As demonstrated in Table 2, while there are variations in 
growth among the transgenic trees, the average length of the 
internodes for the transgenic trees is consistently and sig­
nificantly higher than that of the control plants. Variations in 
the growth of the transgenic trees is normal and to be 
expected. Preferably, a transgenic tree with a particular 
growth rate is selected and this tree is vegetatively propa­
gated to produce an unlimited number of clones that all 
exhibit the identical growth rate.
F. Lignin
Down regulation of lignin pathway CCL results in pro­
duction of trees with reduced lignin content.
The following table shows the reduction of lignin content 
and CCL enzyme activity in several transgenic aspen which 
have been transformed with an homologous antisense CCL 
sequence.
TABLE 3
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Characterization of Transgenic Aspen Plants 
Harboring Antisense CCL Sequence
Lignin 
Content %
Transgenic 
Plant #
Based On 
Wood 
Weight
% Lignin 
Reduction
CCL
Enzyme
Activity*
% CCL Enzyme 
Activity 
Reduction
control 21.4 0.0 868 0
11-1 20.5 4.2 1171 -25
11-2 19.2 10.3 515 45
11-3 20.9 2.3 922 6
11-4 19.7 7.9 1032 -19
11-5 19.7 7.9 691 20
11-7 19.9 7.0 578 38
11-8 20.2 5.6 694 20
11-9 20.4 4.7 806 14
11-10 19.4 9.3 455 51
11-11 20.4 4.7 726 22
12-1 12.8 40.2 49 95
12-2 12.6 41.1 62 93
12-3 11.9 44.4 61 94
12-6 19.8 7.5 786 16
16-1 12.8 40.2 35 96
16-2 20.6 3.7 780 17
16-3 21.0 1.9 795 15
17-1 20.5 4.2 855 9
17-2 21.4 0.0 925 1
^activity is expressed as pkat/(mg protein) using p-coumaric acid as the 
substrate
Lignin content was determined according to Chiang and 
Funaoka (1990) Holzforschung 44:147-155. CCL enzyme 
activity was determined according to Ranjeva et al. (1976), 
Biochimie 58:1255-1262.
The data in Table 3 demonstrates a correlation between 
down regulation of CCL and reduction in lignin content.
Transgenic trees with reduced lignin content have an 
altered phenotype in that the stem is more elastic to the touch 
and the leaves are typically curlier.
It should also be noted that for those transgenic trees 
(12-1, 12-2, 12-3 and 16-1) with the approximately 40% 
reduction in lignin content and the corresponding approxi­
mately 95% reduction in CCL enzyme levels, all of those 
transgenic trees had a consistent deep red coloration in the 
wood of the plant. Accordingly, the deep red color can be 
used as an identifier of reduced lignin content.
Down regulation of lignin pathway CCL also results in 
production of trees with an altered lignin structure. Based
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upon thioacidolysis (Rolando et al. (1992) Thioacidolysis, 
Methods in Lignin Chemistry, Springer-Verlag, Berlin, pp 
334—349) of plants 12-3 and 16-1, coniferyl alcohol and 
sinapyl alcohol lignin units are significantly reduced in these 
two trees as compared to the control tree, as shown in the 
following table.
13
TABLE 4
Altered Lignin Structure
Coniferyl Alcohol Sinapyl Alcohol
Plant # Units* Units*
control 733 1700
12-3 283 592
16-1 247 445
*micro-mole/g of lignin
The alteration of the frequency of the structural units in 
lignin of these transgenic trees is evidence that the overall 
structure of lignin in these plants has been genetically 
altered.
G. Cellulose Content
Down regulation of lignin pathway CCL results in 
increased cellulose content of the transgenic plants. Analysis 
of control and transgenic aspen for carbohydrate content 
demonstrate a higher cellulose content in the transgenic trees 
than the control trees. Particularly, the transgenic trees that 
have over 40% lignin reduction have about 10-15% higher 
cellulose content than the control. Data is set forth in the 
following tables for trees that were transformed with 
homologous CCL in an antisense orientation:
TABLE 5
Analysis of Carbohydrate Components in 
____ Transgenic and Control Aspen_____
Plant # Glucan Arabinan Galactan Rhamnan Xylan Mannan
Control 44.23% 0.47% 0.79% 0.37% 17.19% 1.91%
11-2 49.05% 0.36% 1.05% 0.38% 15.34% 2.04%
11-9 45.95% 0.40% 0.80% 0.37% 17.12% 1.83%
11-10 47.49% 0.43% 0.99% 0.40% 16.24% 2.35%
12-3 50.83% 0.55% 1.24% 0.48% 17.25% 1.77%
16-1 48.14% 0.56% 1.07% 0.48% 19.14% 1.58%
16-2 46.55% 0.34% 0.82% 0.37% 16.75% 2.31%
TABLE 6
Comparison of Lignin and Cellulose (glucan) 
Contents in Transgenic and Control Aspen
lose
Plant #
Lignin Cellu
Content % 
on wood % reduction
Content % 
on wood % increase
Control 21.4 0 44.23 0
11-2 19.2 10.3 49.05 11.0
11-9 20.4 4.7 45.95 3.9
11-10 19.4 9.3 47.49 7.4
12-3 11.9 44.5 50.83 15.0
16-1 12.8 40.2 48.14 6.8
16-2 20.6 3.7 46.55 5.2
The procedure for carbohydrate analysis utilized is as 
follows. About 100 mg of powdery woody tissue with sizes 
that pass a 80-mesh screen was hydrolyzed with 1 mL of 
72% (W/W) H2S04 for 1 hr at 30° C. Samples were then
diluted to 4% (W/W) H2S04 with distilled water, fucose 
was added as an internal standard, and a secondary hydroly­
sis was performed for 1 hr at 121° C. After secondary 
hydrolysis, the sugar contents of the hydrolysates are deter­
mined by anion exchange high performance liquid chroma­
tography using pulsed amperometric detection. Sugar con­
tents are expressed as % of the weight of the woody tissue 
used. The above procedures are similar to those in a publi­
cation by RC Pettersen and VE1 Schwandt, 1991, J. Wood 
Chem & Technol. 11:495-501.
El. Increased Disease Resistance
Down regulation of lignin pathway CCL results in pro­
duction of trees with increased disease resistance, and in 
particular, with increased fungal pathogen resistance.
In particular, greenhouse transgenic aspen plants showed 
a disease resistance to fungi such as those which induce 
leaf-blight disease.
I. Promoters
Two distinct genes encoding CCL and their promoters 
were cloned. The promoter of PtCCLl can drive gene 
expression specifically in xylem tissue and the promotor for 
PtCCL2 confers gene expression exclusively in the epider­
mal tissues. These promoters can be used to manipulate gene 
expression to engineer traits of interest in specific tissues of 
target plants. The significance of the promoters is the appli­
cation of the xylem-specific promoter to direct the expres­
sion of any relevant genes specifically in the xylem for 
engineering lignin content, lignin structure, enhanced tree 
growth, cellulose content and other value-added wood 
qualities, etc. The importance of the epidermis-specific 
promoter is its ability to drive the expression of any relevant 
genes specifically in epidermal tissues for engineering 
disease-, UV light-, cold-, heat-, drought-, and other stress 
resistance traits in trees.
Specifically, the promoters of the PtCCLl and PtCCL2 
were conventionally isolated as follows. An aspen genomic 
library was screened with PtCCLlcDNA and PtCCL2 partial 
cDNA fragment to isolate genomic clones of PtCCLl and 
PtCCL2. Eleven and seven positive genomic clones were 
identified for PtCCLl and PtCC12 gene, respectively. 
Among 11 positive clones for PtCCLl, PtCCLlg-4 con­
tained a full length coding sequence and at least 2 kb 5' 
flanking regions. The restriction map of PtCCLlg-4 is set 
forth at FIG. 3.
With respect to PtCCL2, restriction map analysis was 
performed on EDNA of positive genomic clone PtCCL2g- 
11. The restriction map of PtCCL2g-ll is set forth at FIG. 
4.
Approximately a 2.3 kb 5' flanking region of PtCCLl was 
digested from PtCCLlg-4 using Xba I and Sac I sites and 
cloned into pGEM7Z Xba I and Sac I sites. The subcloned 
PtCCLl promoter was named p7Z-4XS and the restriction 
map of P7Z-4XS is set forth at FIG. 5. The 5' unilateral 
deletion of p7Z-4XS was generated for DNA sequencing by 
exonuclease III/S1 nuclease digestion using Erase-a-Base 
System (Promega, Madison, Wis.). The deletion series was 
sequenced using a primer on pGEM7Z vector.
A 1.6 kb blind III and EcoR I fragment containing a 1.2 
kb 5' flanking region of PtCCL2 and 0.4 kb coding region of 
PtCCL2g-ll were subcloned in pBluescript II SK+ Hind III 
and EcoR I sites. The restriction map of the resulting clone, 
pSK-llHE, was determined by digesting the plasmid with 
several restriction enzymes, as in set forth at FIG. 6. In order
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to determine the sequence of the PtCCL2 promoter, pSK- 
11HE was further digested into small fragments according to 
the restriction map and subcloned into vectors with suitable 
cloning sites. The DNA sequence was determined using 
M13 universal primer and reverse primer on the vector.
The DNA sequences of the two promoters was determined 
and analyzed using ATaq cycle sequencing Kit (USB, 
Cleveland, Ohio), and GENETYX-MAC 7.3 sequence 
analysis software from Software Development Co., Ltd. The 
nucleotide sequence of promoter region of PtCCLl is set 
forth as SEQ ID NO:5 and the nucleotide sequence of the 
promoter region of PtCCL2 is set forth as SEQ ID NO:6. 
The promoter gene constructs PtCCLlp and PtCCL2p are 
available from Michigan Technological University, Institute 
of Wood Research, Eloughton, Mich.
Tissue-specific expression can be achieved by conven­
tionally fusing the promoters of PtCCLl or PtCCL2 to a 
gene of interest and transferred to a plant species via 
Agrobacterium. For the sake of example, the promoters of 
PtCCLl and PtCCL2 were fused to a GUS reporter gene as 
detailed below. However, it should be noted that genes other 
than the GUS reporter gene can be fused to these promoters 
for tissue specific expression.
In order to construct PtCCLl promoter-GUS binary 
vector, a 1 Kb fragment covering 5'-flanking region and 117 
bp coding region of PtCCLl was subcloned into pGEM7Z 25 
Sph I and EcoR I sites for constructing promoter-GUS 
binary vector. In this 1 kb DNA fragment, it is found that one 
Xho I site locates at 486 bases proximal to the translation 
start site and the EcoR I site at 117 bases downstream the 
translation site. This 0.6 Kb fragment was subcloned into 30 
pGEM7Z Xho I and EcoR I sites and used as a template in 
PCR amplification.
In order to construct a promoter-GUS transcriptional 
fusion, a BamH I site was introduced in front of the 
translation start site of PtCCLl by PCR. PCR amplification 35 
was performed using p7Z-4XE as the template, M13 uni­
versal primer on pGEM7Z vector as 5' end primer and 
PtCCLlp-1 primer containing a BamH I site at the end is 
complementary to a sequence upstream of the translation 
start site. The reaction was carried out in 100 fil reaction mix 40 
containing lxpfu reaction buffer, 200 fA each dNTPs, 100 
fiM each primer and 5 units of pfu. The PCR reaction 
mixture was denatured at 94° C. for 5 minutes followed by 
30 cycles of 94° C. (1 minute), 55° C. (1 minute), 72° C. (1 
minute, 30 seconds) and was ended with a 5 minute exten­
sion at 72° C.
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The amplified 0.6 Kb fragment was cloned and sequenced 
to confirm the sequence. The engineered 0.6 Kb fragment 
was ligated to p7Z-4SE which was digested with Xho I and 
BamH I. In order to incorporate a Hind III site in the 5' end 
5 of PtCCLl promoter, the 1 kb Sph I-BamH I 
PtCCLlpromoter region was the cloned into pNoTA (5 
prime—» 3 prime Inc., Boulder, Colo.) Sph I and BamH I site. 
The 1 Kb PtCCLlpromoter was then released from pNoTA 
vector with Hind III and BamH digestion and subsequently 
10 transcriptionally fused to pBUOl Hind III and BamH I sites 
in front of GUS. The resulting binary vector was named 
PtCCLlp-GUS and is set forth at FIG. 7.
In order to construct PtCCL2 promoter-GUS binary 
35 vector, pSK-llHE was digested with Sph I and EcoR I to 
release 0.2 Kb Sph I and EcoR I fragment. The 0.2 Kb 
fragment was cloned into pGEM7Z Sph I and EcoR I sites. 
A p r im er ,  P t C C L 2 p -3 '  (5 ' -
CATCGGATCCTGAGATGGAAGGGAGTTTCT-3')(SEQ 
20 ID NO:14) was designed to be complementary to a sequence 
upstream of the translation start site of PtCCL2 and to 
incorporate BamH I site at the end. Amplification was 
performed using p7ZllSE as a template, M13 universal 
primer as the 5' end primer and PtCCL2p-3 as the 3' end 
primer. A PCR reaction was carried out and the amplified 
PCR product was cloned and sequenced to check the fidelity 
of the PCR amplification. The 0.2 Kb Sph I-BamH I DNA 
fragment with correct sequence was fused to pSK-llHE 
linearized with Sph I and BamH I. The resulting plasmid was 
named pSK-llHB. The promoter of PtCCL2 was then 
excised from pSK-llHB with Hind III and BamH I and 
ligated to PBI101 Hind III and BamH I site to make 
PtCCL2p-GUS transcriptional fusion binary vector as 
shown in FIG. 8.
The PtCCLlp-GUS and PtCCL2p-GUS constructs are 
then mobilized into Agrobacterium tumefaciens strain C58/ 
pMP90 by freeze and thaw method as explained previously.
Leaf disk transformation of tobacco with these two Agro­
bacterium constructs is conducted according to the method 
of Horsch R. B. (1988) Leaf Disk Transformation, Plant 
Molecular Biology Manual, A5:l-9. Histochemical GUS 
staining of promoter-GUS transgenic tobacco plants dem­
onstrated that the PtCCLl promoter restricted GUS expres­
sion in xylem tissue whereas PtCCL2 promoter regulated 
GUS expression in epidermal cells.
16
SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 15
<210> SEQ ID NO 1 
<211> LENGTH: 1915 
<212> TYPE: DNA
<213> ORGANISM: Populus tremuloides Michx.
<220> FEATURE:
<221> NAME/KEY: CDS
<222> LOCATION: ( 83 ) . . . ( 1687 )
<400> SEQUENCE: 1
ccctcgcgaa actccgaaaa cagagagcac ctaaaactca ccatctctcc ctctgcatct 60
ttagcccgca atggacgcca ca atg aat cca caa gaa ttc ate ttt ege tea 
Met Asn Pro Gin Glu Phe lie Phe Arg Ser 
1 5  10
112
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17 18
-continued
aaa tta cca gac ate tac ate ccg aaa aac ett ccc ctg cat tea tac 160
Lys Leu Pro Asp lie Tyr lie Pro Lys Asn Leu Pro Leu His Ser Tyr
15 20 25
gtt ett gag aac ttg tet aaa cat tea tea aaa cct tgc ctg ata aat 208
Val Leu Glu Asn Leu Ser Lys His Ser Ser Lys Pro Cys Leu lie Asn
30 35 40
ggc geg aat gga gat gtc tac acc tat get gat gtt gag etc aca gca 256
Gly Ala Asn Gly Asp Val Tyr Thr Tyr Ala Asp Val Glu Leu Thr Ala
45 50 55
aga aga gtt get tet ggt ctg aac aag att ggt att caa caa ggt gac 304
Arg Arg Val Ala Ser Gly Leu Asn Lys lie Gly lie Gin Gin Gly Asp
60 65 70
gtg ate atg etc ttc eta cca agt tea cct gaa ttc gtg ett get ttc 352
Val lie Met Leu Phe Leu Pro Ser Ser Pro Glu Phe Val Leu Ala Phe
75 80 85 90
eta ggc get tea cac aga ggt gee atg ate act get gee aat cct ttc 400
Leu Gly Ala Ser His Arg Gly Ala Met lie Thr Ala Ala Asn Pro Phe
95 100 105
tcc acc cct gca gag eta gca aaa cat gee aag gee teg aga gca aag 448
Ser Thr Pro Ala Glu Leu Ala Lys His Ala Lys Ala Ser Arg Ala Lys
110 115 120
ett ctg ata aca cag get tgt tac tac gag aag gtt aaa gat ttt gee 496
Leu Leu lie Thr Gin Ala Cys Tyr Tyr Glu Lys Val Lys Asp Phe Ala
125 130 135
ega gaa agt gat gtt aag gtc atg tgc gtg gac tet gee ccg gac ggt 544
Arg Glu Ser Asp Val Lys Val Met Cys Val Asp Ser Ala Pro Asp Gly
140 145 150
get tea ett ttc aga get cac aca cag gca gac gaa aat gaa gtg cct 592
Ala Ser Leu Phe Arg Ala His Thr Gin Ala Asp Glu Asn Glu Val Pro
155 160 165 170
cag gtc gac att agt cct gat gat gtc gta gca ttg cct tat tea tea 640
Gin Val Asp lie Ser Pro Asp Asp Val Val Ala Leu Pro Tyr Ser Ser
175 180 185
g g g act aca g g g ttg cca aaa g g g gtc atg tta aeg cac aaa g g g eta 688
Gly Thr Thr Gly Leu Pro Lys Gly Val Met Leu Thr His Lys Gly Leu
190 195 200
ata acc agt gtg get caa cag gta gat gga gac aat cct aac ctg tat 736
lie Thr Ser Val Ala Gin Gin Val Asp Gly Asp Asn Pro Asn Leu Tyr
205 210 215
ttt cac agt gaa gat gtg att ctg tgt gtg ett cct atg ttc cat ate 784
Phe His Ser Glu Asp Val lie Leu Cys Val Leu Pro Met Phe His lie
220 225 230
tat get ctg aat tea atg atg etc tgt ggt ctg aga gtt ggt gee teg 832
Tyr Ala Leu Asn Ser Met Met Leu Cys Gly Leu Arg Val Gly Ala Ser
235 240 245 250
att ttg ata atg cca aag ttt gag att ggt tet ttg ctg gga ttg att 880
lie Leu lie Met Pro Lys Phe Glu lie Gly Ser Leu Leu Gly Leu lie
255 260 265
gag aag tac aag gta tet ata gca cca gtt gtt cca cct gtg atg atg 928
Glu Lys Tyr Lys Val Ser lie Ala Pro Val Val Pro Pro Val Met Met
270 275 280
gca att get aag tea cct gat ett gac aag cat gac ctg tet tet ttg 976
Ala lie Ala Lys Ser Pro Asp Leu Asp Lys His Asp Leu Ser Ser Leu
285 290 295
agg atg ata aaa tet gga g g g get cca ttg ggc aag gaa ett gaa gat 1024
Arg Met lie Lys Ser Gly Gly Ala Pro Leu Gly Lys Glu Leu Glu Asp
300 305 310
act gtc aga get aag ttt cct cag get aga ett ggt cag gga tat gga 1072
Thr Val Arg Ala Lys Phe Pro Gin Ala Arg Leu Gly Gin Gly Tyr Gly
315 320 325 330
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19 20
-continued
atg acc gag gca gga o o r+ gtt eta gca atg tgc ttg gca ttt gcc aag 1120
Met Thr Glu Ala Gly Pro Val Leu Ala Met Cys Leu Ala Phe Ala Lys
335 340 345
gaa cca ttc gac ata aaa cca ggt gca tgt gga act gta gtc agg aat 1168
Glu Pro Phe Asp lie Lys Pro Gly Ala Cys Gly Thr Val Val Arg Asn
350 355 360
gca gag atg aag att gtt gac cca gaa aca g g g gtc tet eta ccg agg 1216
Ala Glu Met Lys lie Val Asp Pro Glu Thr Gly Val Ser Leu Pro Arg
365 370 375
aac cag cct ggt gag ate tgc ate egg ggt gat cag ate atg aaa gga 1264
Asn Gin Pro Gly Glu lie Cys lie Arg Gly Asp Gin lie Met Lys Gly
380 385 390
tat ett aat gac ccc gag gca acc tea aga aca ata gac aaa gaa gga 1312
Tyr Leu Asn Asp Pro Glu Ala Thr Ser Arg Thr lie Asp Lys Glu Gly
395 400 405 410
tgg ctg cac aca ggc gat ate ggc tac att gat gat gat gat gag ett 1360
Trp Leu His Thr Gly Asp lie Gly Tyr lie Asp Asp Asp Asp Glu Leu
415 420 425
ttc ate gtt gac aga ttg aag gaa ttg ate aag tat aaa g g g ttt cag 1408
Phe lie Val Asp Arg Leu Lys Glu Leu lie Lys Tyr Lys Gly Phe Gin
430 435 440
gtt get cct act gaa etc gaa get ttg tta ata gcc cat cca gag ata 1456
Val Ala Pro Thr Glu Leu Glu Ala Leu Leu lie Ala His Pro Glu lie
445 450 455
rt o o gat get get gta gta gga ttg aaa gat gag gat geg gga gaa gtt 1504
Ser Asp Ala Ala Val Val Gly Leu Lys Asp Glu Asp Ala Gly Glu Val
460 465 470
o o r+ gtt gca ttt gta gtg aaa tea gaa aag tet cag gcc acc gaa gat 1552
Pro Val Ala Phe Val Val Lys Ser Glu Lys Ser Gin Ala Thr Glu Asp
475 480 485 490
gaa att aag cag tat att tea aaa cag gtg ate ttc tac aag aga ata 1600
Glu lie Lys Gin Tyr lie Ser Lys Gin Val lie Phe Tyr Lys Arg lie
495 500 505
aaa ega gtt ttc ttc att gaa gca att ccc aag gca cca tea ggc aag 1648
Lys Arg Val Phe Phe lie Glu Ala lie Pro Lys Ala Pro Ser Gly Lys
510 515 520
ate ctg agg aag aat ctg aaa gag aag ttg cca ggc ata taactgaaga 1697
lie Leu Arg Lys Asn Leu Lys Glu Lys Leu Pro Gly lie
525 530 535
tgttactgaa catttaaccc tctgtcttat ttctttaata ettgegaate attgtagtgt 1757
tgaaccaagc atgcttggaa aagacacgta cccaacgtaa gacagttact gttcctagta 1817
tacaagctct ttaatgttcg ttttgaactt gggaaaacat aagttctcct gtcgccatat 1877
ggagtaattc aattgaatat tttggtttct ttaatgat 1915
<210> SEQ ID NO 2 
<2 11> LENGTH: 535 
<212> TYPE: PRT
<213> ORGANISM: Populus tremuloides Michx. 
<400> SEQUENCE: 2
Met
1
Asn Pro Gin Glu
5
Phe lie Phe Arg Ser
10
Lys Leu Pro Asp lie
15
Tyr
lie Pro Lys Asn
20
Leu Pro Leu His Ser
25
Tyr Val Leu Glu Asn
30
Leu Ser
Lys His Ser
35
Ser Lys Pro Cys Leu
40
lie Asn Gly Ala Asn
45
Gly Asp Val
Tyr Thr Tyr Ala Asp Val Glu Leu Thr Ala Arg Arg Val Ala Ser Gly
US 6,455,762 B1
21 22
-continued
50 55 60
Leu Asn Lys lie Gly lie Gin Gin Gly Asp Val lie Met Leu Phe Leu
65 70 75 80
Pro Ser Ser Pro Glu Phe Val Leu Ala Phe Leu Gly Ala Ser His Arg
85 90 95
Gly Ala Met lie Thr Ala Ala Asn Pro Phe Ser Thr Pro Ala Glu Leu
100 105 110
Ala Lys His Ala Lys Ala Ser Arg Ala Lys Leu Leu lie Thr Gin Ala
115 120 125
Cys Tyr Tyr Glu Lys Val Lys Asp Phe Ala Arg Glu Ser Asp Val Lys
130 135 140
Val Met Cys Val Asp Ser Ala Pro Asp Gly Ala Ser Leu Phe Arg Ala
145 150 155 160
His Thr Gin Ala Asp Glu Asn Glu Val Pro Gin Val Asp lie Ser Pro
165 170 175
Asp Asp Val Val Ala Leu Pro Tyr Ser Ser Gly Thr Thr Gly Leu Pro
180 185 190
Lys Gly Val Met Leu Thr His Lys Gly Leu lie Thr Ser Val Ala Gin
195 200 205
Gin Val Asp Gly Asp Asn Pro Asn Leu Tyr Phe His Ser Glu Asp Val
210 215 220
lie Leu Cys Val Leu Pro Met Phe His lie Tyr Ala Leu Asn Ser Met
225 230 235 240
Met Leu Cys Gly Leu Arg Val Gly Ala Ser lie Leu lie Met Pro Lys
245 250 255
Phe Glu lie Gly Ser Leu Leu Gly Leu lie Glu Lys Tyr Lys Val Ser
260 265 270
lie Ala Pro Val Val Pro Pro Val Met Met Ala lie Ala Lys Ser Pro
275 280 285
Asp Leu Asp Lys His Asp Leu Ser Ser Leu Arg Met lie Lys Ser Gly
290 295 300
Gly Ala Pro Leu Gly Lys Glu Leu Glu Asp Thr Val Arg Ala Lys Phe
305 310 315 320
Pro Gin Ala Arg Leu Gly Gin Gly Tyr Gly Met Thr Glu Ala Gly Pro
325 330 335
Val Leu Ala Met Cys Leu Ala Phe Ala Lys Glu Pro Phe Asp lie Lys
340 345 350
Pro Gly Ala Cys Gly Thr Val Val Arg Asn Ala Glu Met Lys lie Val
355 360 365
Asp Pro Glu Thr Gly Val Ser Leu Pro Arg Asn Gin Pro Gly Glu lie
370 375 380
Cys lie Arg Gly Asp Gin lie Met Lys Gly Tyr Leu Asn Asp Pro Glu
385 390 395 400
Ala Thr Ser Arg Thr lie Asp Lys Glu Gly Trp Leu His Thr Gly Asp
405 410 415
lie Gly Tyr lie Asp Asp Asp Asp Glu Leu Phe lie Val Asp Arg Leu
420 425 430
Lys Glu Leu lie Lys Tyr Lys Gly Phe Gin Val Ala Pro Thr Glu Leu
435 440 445
Glu Ala Leu Leu lie Ala His Pro Glu lie Ser Asp Ala Ala Val Val
450 455 460
Gly Leu Lys Asp Glu Asp Ala Gly Glu Val Pro Val Ala Phe Val Val
465 470 475 480
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Lys Ser Glu Lys Ser Gin Ala Thr Glu Asp Glu lie Lys Gin Tyr lie
485 490 495
Ser Lys Gin Val lie Phe Tyr Lys Arg lie Lys Arg Val Phe Phe lie
500 505 510
Glu Ala lie Pro Lys Ala Pro Ser Gly Lys lie Leu Arg Lys Asn Leu
515 520 525
Lys Glu Lys Leu Pro Gly lie
530 535
<210> SEQ ID NO 3 
<2 11> LENGTH: 1710 
<212> TYPE: DNA
<213> ORGANISM: Populus tremuloides Michx. 
<220> FEATURE:
<221> NAME/KEY: CDS
<222> LOCATION: (1)...(1710)
<400> SEQUENCE: 3
atg atg rt o o gtg gcc aeg gtt gag ccc ccg aaa ccg gaa etc tcc cct 48
Met Met Ser Val Ala Thr Val Glu Pro Pro Lys Pro Glu Leu Ser Pro
1 5 10 15
cca caa aac caa aac gca cca tcc tet cat gaa act gat cac att ttc 96
Pro Gin Asn Gin Asn Ala Pro Ser Ser His Glu Thr Asp His lie Phe
20 25 30
aga tea aaa eta cca gac ata acc ate teg aac gac etc cct ctg cac 144
Arg Ser Lys Leu Pro Asp lie Thr lie Ser Asn Asp Leu Pro Leu His
35 40 45
gca tac tgc ttt gaa aac etc tet gat ttc tea gat agg cca tgc ttg 192
Ala Tyr Cys Phe Glu Asn Leu Ser Asp Phe Ser Asp Arg Pro Cys Leu
50 55 60
att tea ggt tcc aeg gga aaa acc tat tet ttt gcc gaa act cac etc 240
lie Ser Gly Ser Thr Gly Lys Thr Tyr Ser Phe Ala Glu Thr His Leu
65 70 75 80
ata tet egg aag gtc get get g g g tta tcc aat ttg ggc ate aag aaa 288
lie Ser Arg Lys Val Ala Ala Gly Leu Ser Asn Leu Gly lie Lys Lys
85 90 95
ggc gat gta ate atg acc ctg etc caa aac tgc cca gaa ttc gtc ttc 336
Gly Asp Val lie Met Thr Leu Leu Gin Asn Cys Pro Glu Phe Val Phe
100 105 110
tcc ttc ate ggt get tcc atg att ggt gca gtc ate acc act gcg aac 384
Ser Phe lie Gly Ala Ser Met lie Gly Ala Val lie Thr Thr Ala Asn
115 120 125
cct ttc tac act caa agt gaa ata ttc aag caa ttc tet get tet cgt 432
Pro Phe Tyr Thr Gin Ser Glu lie Phe Lys Gin Phe Ser Ala Ser Arg
130 135 140
gcg aaa ctg att ate acc cag tet caa tat gtg aac aag eta gga gat 480
Ala Lys Leu lie lie Thr Gin Ser Gin Tyr Val Asn Lys Leu Gly Asp
145 150 155 160
agt gat tgc cat gaa aac aac caa aaa ccg g g g gaa gat ttc ata gta 528
Ser Asp Cys His Glu Asn Asn Gin Lys Pro Gly Glu Asp Phe lie Val
165 170 175
ate acc att gat gac ccg cca gag aac tgt eta cat ttc aat gtg ett 576
lie Thr lie Asp Asp Pro Pro Glu Asn Cys Leu His Phe Asn Val Leu
180 185 190
gtc gag get age gag agt gaa atg cca aca gtt tea ate ett ccg gat 624
Val Glu Ala Ser Glu Ser Glu Met Pro Thr Val Ser lie Leu Pro Asp
195 200 205
gat cct gtg gca tta cca ttc tet tea g g g aca aca g g g etc cca aaa 672
Asp Pro Val Ala Leu Pro Phe Ser Ser Gly Thr Thr Gly Leu Pro Lys
210 215 220
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-continued
gga gtg ata ctg ace cac aag age ttg ata aca agt gtg get caa caa 720
Gly Val lie Leu Thr His Lys Ser Leu lie Thr Ser Val Ala Gin Gin
225 230 235 240
gtt gat gga gag ate cca aat tta tac ttg aaa caa gat gac gtt gtt 768
Val Asp Gly Glu lie Pro Asn Leu Tyr Leu Lys Gin Asp Asp Val Val
245 250 255
tta tgc gtt tta cct ttg ttt cac ate ttt tea ttg aac age gtg ttg 816
Leu Cys Val Leu Pro Leu Phe His lie Phe Ser Leu Asn Ser Val Leu
260 265 270
tta tgc teg ttg aga gee ggt tet get gtt ett tta atg caa aag ttt 864
Leu Cys Ser Leu Arg Ala Gly Ser Ala Val Leu Leu Met Gin Lys Phe
275 280 285
gag ata gga tea ctg eta gag etc att cag aaa cac aat gtt teg gtt 912
Glu lie Gly Ser Leu Leu Glu Leu lie Gin Lys His Asn Val Ser Val
290 295 300
gcg get gtg gtg cca cca ctg gtg ctg gcg ttg gee aag aac cca ttg 960
Ala Ala Val Val Pro Pro Leu Val Leu Ala Leu Ala Lys Asn Pro Leu
305 310 315 320
gag gcg aac ttc gac ttg agt teg ate agg gta gtc ctg tea g g g get 1008
Glu Ala Asn Phe Asp Leu Ser Ser lie Arg Val Val Leu Ser Gly Ala
325 330 335
gcg cca ctg g g g aag gag etc gag gac gee etc agg age agg gtt cct 1056
Ala Pro Leu Gly Lys Glu Leu Glu Asp Ala Leu Arg Ser Arg Val Pro
340 345 350
cag gee ate ctg gga cag ggt tat g g g atg aca gag gee g g g cct gtg 1104
Gin Ala lie Leu Gly Gin Gly Tyr Gly Met Thr Glu Ala Gly Pro Val
355 360 365
eta tea atg tgc tta gee ttt tea aag caa cct ttc cca acc aag tet 1152
Leu Ser Met Cys Leu Ala Phe Ser Lys Gin Pro Phe Pro Thr Lys Ser
370 375 380
g g g teg tgt gga aeg gtg gtt aga aac gca gag etc aag gtc att gac 1200
Gly Ser Cys Gly Thr Val Val Arg Asn Ala Glu Leu Lys Val lie Asp
385 390 395 400
cct gag ace ggt ege tet ett ggt tac aac caa cct ggt gaa ate tgc 1248
Pro Glu Thr Gly Arg Ser Leu Gly Tyr Asn Gin Pro Gly Glu lie Cys
405 410 415
ate cgt gga tee caa ate atg aaa gga tat ttg aat gac gcg gaa gee 1296
lie Arg Gly Ser Gin lie Met Lys Gly Tyr Leu Asn Asp Ala Glu Ala
420 425 430
aeg gca aac ace ata gac gtt gag ggt tgg etc cac act gga gat ata 1344
Thr Ala Asn Thr lie Asp Val Glu Gly Trp Leu His Thr Gly Asp lie
435 440 445
ggt tat gtc gac gac gac gac gag att ttc att gtt gat aga gtg aag 1392
Gly Tyr Val Asp Asp Asp Asp Glu lie Phe lie Val Asp Arg Val Lys
450 455 460
gaa ate ata aaa ttc aaa ggc ttc cag gtg ccg cca gcg gag ett gag 1440
Glu lie lie Lys Phe Lys Gly Phe Gin Val Pro Pro Ala Glu Leu Glu
465 470 475 480
get etc ett gta aac cac cct tea att gcg gat gcg get gtt gtt ccg 1488
Ala Leu Leu Val Asn His Pro Ser lie Ala Asp Ala Ala Val Val Pro
485 490 495
caa aaa gac gag gtt get ggt gaa gtt cct gtc gcg ttt gtg gtc ege 1536
Gin Lys Asp Glu Val Ala Gly Glu Val Pro Val Ala Phe Val Val Arg
500 505 510
tea gat gat ett gac ett agt gaa gag get gta aaa gaa tac att gca 1584
Ser Asp Asp Leu Asp Leu Ser Glu Glu Ala Val Lys Glu Tyr lie Ala
515 520 525
aag cag gtg gtg ttc tac aag aaa ctg cac aag gtg ttc ttc gtt cat 1632
Lys Gin Val Val Phe Tyr Lys Lys Leu His Lys Val Phe Phe Val His
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530 535 540
tct att ccc aaa teg get tet gga aag att eta aga aaa gac etc aga
Ser lie Pro Lys Ser Ala Ser Gly Lys lie Leu Arg Lys Asp Leu Arg
545 550 555 560
gcc aag ctt gcc aca gcc acc acc atg tcc
Ala Lys Leu Ala Thr Ala Thr Thr Met Ser
565 570
<210> SEQ ID' NO 4
<2 11> LENGTH:: 570
<2 12> TYPE: PRT
<2 13> ORGANISM: Populus tremuloides Michx.
<400> SEQUENCE: 4
Met Met Ser Val Ala Thr Val Glu Pro Pro Lys Pro Glu Leu Ser Pro
1 5 10 15
Pro Gin Asn Gin Asn Ala Pro Ser Ser His Glu Thr Asp His lie Phe
20 25 30
Arg Ser Lys Leu Pro Asp lie Thr lie Ser Asn Asp Leu Pro Leu His
35 40 45
Ala Tyr Cys Phe Glu Asn Leu Ser Asp Phe Ser Asp Arg Pro Cys Leu
50 55 60
lie Ser Gly Ser Thr Gly Lys Thr Tyr Ser Phe Ala Glu Thr His Leu
65 70 75 80
lie Ser Arg Lys Val Ala Ala Gly Leu Ser Asn Leu Gly lie Lys Lys
85 90 95
Gly Asp Val lie Met Thr Leu Leu Gin Asn Cys Pro Glu Phe Val Phe
100 105 110
Ser Phe lie Gly Ala Ser Met lie Gly Ala Val lie Thr Thr Ala Asn
115 120 125
Pro Phe Tyr Thr Gin Ser Glu lie Phe Lys Gin Phe Ser Ala Ser Arg
130 135 140
Ala Lys Leu lie lie Thr Gin Ser Gin Tyr Val Asn Lys Leu Gly Asp
145 150 155 160
Ser Asp Cys His Glu Asn Asn Gin Lys Pro Gly Glu Asp Phe lie Val
165 170 175
lie Thr lie Asp Asp Pro Pro Glu Asn Cys Leu His Phe Asn Val Leu
180 185 190
Val Glu Ala Ser Glu Ser Glu Met Pro Thr Val Ser lie Leu Pro Asp
195 200 205
Asp Pro Val Ala Leu Pro Phe Ser Ser Gly Thr Thr Gly Leu Pro Lys
210 215 220
Gly Val lie Leu Thr His Lys Ser Leu lie Thr Ser Val Ala Gin Gin
225 230 235 240
Val Asp Gly Glu lie Pro Asn Leu Tyr Leu Lys Gin Asp Asp Val Val
245 250 255
Leu Cys Val Leu Pro Leu Phe His lie Phe Ser Leu Asn Ser Val Leu
260 265 270
Leu Cys Ser Leu Arg Ala Gly Ser Ala Val Leu Leu Met Gin Lys Phe
275 280 285
Glu lie Gly Ser Leu Leu Glu Leu lie Gin Lys His Asn Val Ser Val
290 295 300
Ala Ala Val Val Pro Pro Leu Val Leu Ala Leu Ala Lys Asn Pro Leu
305 310 315 320
Glu Ala Asn Phe Asp Leu Ser Ser lie Arg Val Val Leu Ser Gly Ala
1680
1710
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-continued
325 330 335
Ala Pro Leu Gly Lys Glu Leu Glu Asp Ala Leu Arg Ser Arg Val Pro
340 345 350
Gin Ala lie Leu Gly Gin Gly Tyr Gly Met Thr Glu Ala Gly Pro Val
355 360 365
Leu Ser Met Cys Leu Ala Phe Ser Lys Gin Pro Phe Pro Thr Lys Ser
370 375 380
Gly Ser Cys Gly Thr Val Val Arg Asn Ala Glu Leu Lys Val lie Asp
385 390 395 400
Pro Glu Thr Gly Arg Ser Leu Gly Tyr Asn Gin Pro Gly Glu lie Cys
405 410 415
lie Arg Gly Ser Gin lie Met Lys Gly Tyr Leu Asn Asp Ala Glu Ala
420 425 430
Thr Ala Asn Thr lie Asp Val Glu Gly Trp Leu His Thr Gly Asp lie
435 440 445
Gly Tyr Val Asp Asp Asp Asp Glu lie Phe lie Val Asp Arg Val Lys
450 455 460
Glu lie lie Lys Phe Lys Gly Phe Gin Val Pro Pro Ala Glu Leu Glu
465 470 475 480
Ala Leu Leu Val Asn His Pro Ser lie Ala Asp Ala Ala Val Val Pro
485 490 495
Gin Lys Asp Glu Val Ala Gly Glu Val Pro Val Ala Phe Val Val Arg
500 505 510
Ser Asp Asp Leu Asp Leu Ser Glu Glu Ala Val Lys Glu Tyr lie Ala
515 520 525
Lys Gin Val Val Phe Tyr Lys Lys Leu His Lys Val Phe Phe Val His
530 535 540
Ser lie Pro Lys Ser Ala Ser Gly Lys lie Leu Arg Lys Asp Leu Arg
545 550 555 560
Ala Lys Leu Ala Thr Ala Thr Thr Met Ser
565 570
<210> SEQ ID' NO 5
<2 11> LENGTH:: 1172
<2 12> TYPE: DNA
<2 13> ORGANISM: Populus tremuloides Michx.
<400> SEQUENCE: 5
tgtaggattg gtggaatggg atcattccta atcccttaat gacggtggca tgaacacaaa 60
gcaaagagaa gttaggtcac tcctccttta tatatatata tatatgcatg catgaggacc 120
atggctatga tgaaggttaa tagaggtagt tgtgattgag atatgtccag cactagtttt 180
ttgttggtgt gatttctcat gatgacgcga aaattttata tatatatata atgaataata 240
tgattgatta ttctctgtaa ttttgtgaaa tagattaaaa cagctcaatg tgaggtgaoo 300
agttgtcaaa tgaccactcg acttggggca tggtgatttt tcaaatcaca actcaatttg 360
aaaactaaaa ttaaaaaaga tttagattat taaattatta ggttaattca egggttggot 420
aatcaattat tattaattaa aacgatagta tttttgataa tttaattaaa attttattgg 480
atttgaatga actcaattac atcacaaaaa acctaatcaa attaatatct tatgtgatat 540
aatttagaaa tataaatgat taacctttaa atctcgagtt tctcttataa aaaacacgta 600
taattgggct agatttaaca gctattattc aaactggcca ggacaattat taaaattaat 660
aattattatt ttttctaata aagcacttcc taattgttaa aatatatgtc taaacactaa 720
31
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taataaaatt tatttgtgta tctttggcag taggtgagag gtgctgacaa ataaattagt 780
gcataaaata taatggattg gtggtctgtg aaaagacagg tggaggacaa gccacctctc 840
tcaagtcaaa aggccatttc acaaccaacc caaatgggaa cccaccaccg ttccccgcca 900
ttaaaatccc taatctcacc aacccaactc cacagattct tcaccaaacg caactgattt 960
ttcaatcaat gttttcccta tactaccccc ccaacaactc cataataccc aatttgtcct 1020
ttcaccaacc cccgtcctcc gtgccagcca attctatatc agcaggaatg ctctgcactc 1080
tgctttctca ggtctcctac cataagaaaa cagagagcac ctaaaactcg ccatctctcc 1140
ctctgcatct ttagcccgca atggacgcga ca 1172
<210> SEQ ID NO 6 
<2 11> LENGTH: 1180 
<212> TYPE: DNA
<213> ORGANISM: Populus tremuloides Michx.
<400> SEQUENCE: 6
aagctttgag tattcatatg ggtattcatc cgaccattat ttttcaattt gtgttgtgtt 60
gatccaattt tcaacttatt tttttttcac ttatttttta ttagttattt ttatttttat 120
tattttttta aaaatttaaa aattaaatta taacattttt attttatccc tcattaacta 180
aaatagggat ggtaatagat attcatgaag ggagttatat atcaaatgat attagttaag 240
ctattttgat atttataccc tactcattac ttatggaata aaaaatttag atatttataa 300
aatatttatc ggatttcagg tattcatatg aatatttatt tgattattat ttattcaaca 360
aaaaataaaa caattaatat gcatgtttga agtttatata tatattaagt taggtttaga 420
tagattttgg gtggggttaa ttaatattca taccctatct actatctatc aaataatcca 480
aataaattca cctaaattag gttgggtttg tattcatcaa gttaacatta aattgtaatt 540
ccgtaagtaa ctaaacaagt acaaagactt ctattttatc ttatatatta ccataaagcc 600
aactatattt cctattcttt ttcatccctt ctatcgtaat tttctgtgac ttttttattt 660
atatattaac ggtaacgaaa cacagcaata aaagttattg tgaaagatat ggataattat 720
tatggtgact atgaaagagt aaatttgcca tgcactaagt tcctagtgtc atctcataaa 780
agacttgtct gccacgtaag ctgttgtgag tgtcgtttat ttacgcgtgt caaccaatcg 840
ctgccaattg actcttgagg gtaggtgaga gcttcggctt tgatgggaac tgcatgaggc 900
atagggtttg gtttcttgaa tgtgagatgg gcatgctttg gctcccttgc tactcacctc 960
atcttcaatt tgccagctca gctaccagtc tctcaccact agtttcacca aactttctct 1020
gctcctgtat ttattacacc ttgctcgatt ggctccgtcc tcgtacacgc atccacaccg 1080
atcgatcgat tagaaccata cagaattggg attggttggg tttacattct gcgttagata 1140
catctatcac agaaagaaac tcccttccat ctcaggaaac 1180
<210> SEQ ID NO 7 
<2 11> LENGTH: 11 
<212> TYPE: PRT
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Highly conserved region of amino acids as 
determined following alignment of cloned plant CCL 
sequences.
<400> SEQUENCE: 7
Ser Ser Gly Thr Thr Gly Leu Pro Lys Gly Val 
1 5  10
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<2 10> 
<2 11>
SEQ ID NO 8 
LENGTH: 7
<2 12> 
<2 13> 
<220> 
<223>
TYPE: PRT
ORGANISM: Artificial Sequence 
FEATURE:
OTHER INFORMATION: Highly conserved region of amino acids as 
determined following alignment of cloned plant CCL 
sequences.
AooV SEQUENCE: 8
Gly Glu lie Cys lie Arg Gly
1 5
<2 10> 
<2 11>
SEQ ID NO 9 
LENGTH: 31
<2 12> 
<2 13> 
<220> 
<223>
TYPE: DNA
ORGANISM: Artificial Sequence 
FEATURE:
OTHER INFORMATION: Sense primer designed around the first 
consensus AMP-binding region of CCL.
<220>
<221>
<222>
FEATURE:
NAME/KEY: modified_base 
LOCATION: (11)...(11)
<223>
<220>
<221>
<222>
OTHER INFORMATION: I 
FEATURE:
NAME/KEY: modified_base 
LOCATION: (14)...(14)
<223>
<220>
<221>
<222>
OTHER INFORMATION: I 
FEATURE:
NAME/KEY: modified_base 
LOCATION: (17)...(17)
<223>
<220>
<221>
<222>
OTHER INFORMATION: I 
FEATURE:
NAME/KEY: modified_base 
LOCATION: (20)...(20)
<223>
<220>
<221>
OTHER INFORMATION: I 
FEATURE:
NAME/KEY: modified_base
<222>
<223>
<220>
<221>
LOCATION: (23)...(23) 
OTHER INFORMATION: I 
FEATURE:
NAME/KEY: modified_base
<222>
<223>
LOCATION: (26)...(26) 
OTHER INFORMATION: I
AooV SEQUENCE: 9
ttggatccgg aacaacagga ytaccaaarg g 31
<2 10>
<2 11> 
<2 12> 
<2 13>
SEQ ID NO 10 
LENGTH: 28 
TYPE: DNA
ORGANISM: Artificial Sequence
<220>
<223>
FEATURE:
OTHER INFORMATION: Sense primer designed around the first 
consensus AMP-binding region of CCL.
<220> FEATURE:
<221>
<222>
<223>
<220>
NAME/KEY: modified_base 
LOCATION: (11)...(11) 
OTHER INFORMATION: I 
FEATURE:
<221>
<222>
<223>
NAME/KEY: modified_base 
LOCATION: (14)...(14) 
OTHER INFORMATION: I
<220>
<221>
<222>
<223>
FEATURE:
NAME/KEY: modified_base 
LOCATION: (23)...(23) 
OTHER INFORMATION: I
AooV SEQUENCE: 10
ttggatccgt agcacarcar gtagaygg 28
<210> SEQ ID NO 11
35
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<2 11> LENGTH: 27 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Antisense primer designed based on the
sequence of the putative catalytic motif GEICIRG (SEQ ID NO:12). 
<220> FEATURE:
<221> NAME/KEY: modified_base 
<222> LOCATION: (10)...(10)
<223> OTHER INFORMATION: I 
<220> FEATURE:
<221> NAME/KEY: modified_base 
<222> LOCATION: (25 )...(25)
<223> OTHER INFORMATION: I
<400> SEQUENCE: 11
atgtcgacca cgdatrcada tytcacc 27
<210> SEQ ID NO 12 
<2 11> LENGTH: 27 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Primer designed based on the genomic 
sequence of PtCCL2.
<400> SEQUENCE: 12
tctgtctaga tgatgtcgtg gccacgg 27
<210> SEQ ID NO 13 
<2 11> LENGTH: 26 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: Primer designed based on the genomic 
sequence of PtCCL2.
<400> SEQUENCE: 13
ttagatctct aggacatggt ggtggc 26
<210> SEQ ID NO 14 
<2 11> LENGTH: 30 
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence 
<220> FEATURE:
<223> OTHER INFORMATION: A primer designed to be complementary to a 
sequence upstream of the translation start site of 
PtCCL2 and to incorporate BamH I site at the end.
<400> SEQUENCE: 14
catcggatcc tgagatggaa gggagtttct 30
<210> SEQ ID NO 15 
<2 11> LENGTH: 1927 
<212> TYPE: DNA
<213> ORGANISM: Petroselinum crispum 
<220> FEATURE:
<221> NAME/KEY: CDS
<222> LOCATION: ( 64 ) . . . ( 1698 )
<400> SEQUENCE: 15
gaattcccat catcgtttca acaccaaaaa cacacacaca actcatattt tcatattttc 60
ata atg gga gac tgt gta gca ccc aaa gaa gac ctt att ttc cga teg 108
Met Gly Asp Cys Val Ala Pro Lys Glu Asp Leu lie Phe Arg Ser
1 5  10 15
aaa etc cct gat att tac ate ccg aaa cac ctt ccg tta cat act tat
Lys Leu Pro Asp lie Tyr lie Pro Lys His Leu Pro Leu His Thr Tyr
20 25 30
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tgt ttc gaa aac ate teg aaa gtt ggc gac aag rt o o tgt tta ata aat 204
Cys Phe Glu Asn lie Ser Lys Val Gly Asp Lys Ser Cys Leu lie Asn
35 40 45
ggc get aca ggc gaa aeg ttc act tat tet caa gtt gag etc ett tcc 252
Gly Ala Thr Gly Glu Thr Phe Thr Tyr Ser Gin Val Glu Leu Leu Ser
50 55 60
agg aaa gtt gca tea g g g tta aac aaa etc ggc att caa cag ggc gat 300
Arg Lys Val Ala Ser Gly Leu Asn Lys Leu Gly lie Gin Gin Gly Asp
65 70 75
acc ate atg ett ttg etc ccc aac tcc cct gag tat ttt ttc get ttc 348
Thr lie Met Leu Leu Leu Pro Asn Ser Pro Glu Tyr Phe Phe Ala Phe
80 85 90 95
tta ggc gca teg tat cgt ggt gca att tet act atg gcc aat ccg ttt 396
Leu Gly Ala Ser Tyr Arg Gly Ala lie Ser Thr Met Ala Asn Pro Phe
100 105 110
ttc act tet get gag gtg ate aaa cag etc aaa gca tcc eta get aag 444
Phe Thr Ser Ala Glu Val lie Lys Gin Leu Lys Ala Ser Leu Ala Lys
115 120 125
etc ata att aeg caa get tgt tac gta gac aaa gtg aaa gac tac gca 492
Leu lie lie Thr Gin Ala Cys Tyr Val Asp Lys Val Lys Asp Tyr Ala
130 135 140
gca gag aaa aat ata cag ate att tgc ate gat gat get cct cag gat 540
Ala Glu Lys Asn lie Gin lie lie Cys lie Asp Asp Ala Pro Gin Asp
145 150 155
tgt tta cat ttc tec aaa ett atg gaa get gat gaa tea gaa atg ccc 588
Cys Leu His Phe Ser Lys Leu Met Glu Ala Asp Glu Ser Glu Met Pro
160 165 170 175
gag gta gtg ate gat tea gac gat gtc gtc geg tta cct tac tea teg 636
Glu Val Val lie Asp Ser Asp Asp Val Val Ala Leu Pro Tyr Ser Ser
180 185 190
ggt act aca gga eta ccg aaa ggt gtt atg ttg acc cac aaa gga ett 684
Gly Thr Thr Gly Leu Pro Lys Gly Val Met Leu Thr His Lys Gly Leu
195 200 205
gtt act age gtg gca caa caa gtt gat gga gac aat ccg aat tta tat 732
Val Thr Ser Val Ala Gin Gin Val Asp Gly Asp Asn Pro Asn Leu Tyr
210 215 220
atg cat age gag gat gtg atg ate tgc ata ttg cct ttg ttt cat att 780
Met His Ser Glu Asp Val Met lie Cys lie Leu Pro Leu Phe His lie
225 230 235
tat teg ett aac geg gtg ttg tgc tgt gga etc aga gca g g g gtg aeg 828
Tyr Ser Leu Asn Ala Val Leu Cys Cys Gly Leu Arg Ala Gly Val Thr
240 245 250 255
ate ttg att atg cag aaa ttt gat att gtg cca ttt ttg gaa ctg ata 876
lie Leu lie Met Gin Lys Phe Asp lie Val Pro Phe Leu Glu Leu lie
260 265 270
cag aaa tat aaa gtt aca att gga ccg ttt gtg cca cca att gtg ttg 924
Gin Lys Tyr Lys Val Thr lie Gly Pro Phe Val Pro Pro lie Val Leu
275 280 285
gca att geg aaa agt cca gtg gtg gat aaa tat gac ttg teg teg gtg 972
Ala lie Ala Lys Ser Pro Val Val Asp Lys Tyr Asp Leu Ser Ser Val
290 295 300
agg aeg gtt atg tet gga get get ccg tta g g g aag gag ett gaa gat 1020
Arg Thr Val Met Ser Gly Ala Ala Pro Leu Gly Lys Glu Leu Glu Asp
305 310 315
get gtt aga get aag ttt cct aat gcc aaa ett ggt cag gga tat gga 1068
Ala Val Arg Ala Lys Phe Pro Asn Ala Lys Leu Gly Gin Gly Tyr Gly
320 325 330 335
atg aca gag gca g g g cca gtt tta gca atg tgc ctg geg ttt gca aag 1116
Met Thr Glu Ala Gly Pro Val Leu Ala Met Cys Leu Ala Phe Ala Lys
US 6,455,762 B1
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340 345 350
gaa cca tac gag ate aaa teg ggt gcc tgt gga act gtt gtg agg aat 1164
Glu Pro Tyr Glu lie Lys Ser Gly Ala Cys Gly Thr Val Val Arg Asn
355 360 365
get gaa atg aaa att gtg gat cct gag ace aac gcc tet ett cca ega 1212
Ala Glu Met Lys lie Val Asp Pro Glu Thr Asn Ala Ser Leu Pro Arg
370 375 380
aac caa ege gga gag att tgc att ega ggt gac caa att atg aaa ggc 1260
Asn Gin Arg Gly Glu lie Cys lie Arg Gly Asp Gin lie Met Lys Gly
385 390 395
tac etc aat gat cct gaa tea aca agg aca aca ata gac gaa gaa ggc 1308
Tyr Leu Asn Asp Pro Glu Ser Thr Arg Thr Thr lie Asp Glu Glu Gly
400 405 410 415
tgg ttg cac aca gga gat ata ggc ttc att gac gac gat gat gag eta 1356
Trp Leu His Thr Gly Asp lie Gly Phe lie Asp Asp Asp Asp Glu Leu
420 425 430
ttt att gtt gat aga ett aag gaa ata ate aaa tac aaa ggc ttc cag 1404
Phe lie Val Asp Arg Leu Lys Glu lie lie Lys Tyr Lys Gly Phe Gin
435 440 445
gtt gcc cct get gaa ett gaa get ctg eta ett act cat cct acc att 1452
Val Ala Pro Ala Glu Leu Glu Ala Leu Leu Leu Thr His Pro Thr lie
450 455 460
rt o o gat get gca gtt gtt ccc atg ata gat gag aaa gca gga gag gtg 1500
Ser Asp Ala Ala Val Val Pro Met lie Asp Glu Lys Ala Gly Glu Val
465 470 475
o o r+ gtg get ttt gtt gtg aga aca aac ggt ttc acc acc act gag gaa 1548
Pro Val Ala Phe Val Val Arg Thr Asn Gly Phe Thr Thr Thr Glu Glu
480 485 490 495
gaa ate aag caa ttc gtc teg aaa cag gtg gtg ttc tac aag aga ata 1596
Glu lie Lys Gin Phe Val Ser Lys Gin Val Val Phe Tyr Lys Arg lie
500 505 510
ttt cgt gta ttt ttt gtt gat gca att ccg aaa tea cca tet gga aag 1644
Phe Arg Val Phe Phe Val Asp Ala lie Pro Lys Ser Pro Ser Gly Lys
515 520 525
att ett ega aag gac ttg aga gca aaa ata gca tcc ggt gat ett ccc 1692
lie Leu Arg Lys Asp Leu Arg Ala Lys lie Ala Ser Gly Asp Leu Pro
530 535 540
aaa taa gtaateteta <:aaacagaaa tggcataaag ctgaagctgt atgtgtatct 1748
Lys
ttacaaagta <aattctacct aaaagagctc: cgagttgtaa cttgtttgta tattttattt 1808
tttgaatgaa <jgaagattta taagatcatgf taatcactca tcaaagttta aatatcatca 1868
tttgtatcac tacattcggt ttttccgatc: ataaacattg attttttcat gttaaaagt 1927
We claim:
1. A method of altering a characteristic of a plant com­
prising the step of incorporating into the genome of the plant
a nucleotide sequence encoding p-coumarate Co-enzyme A 55 
ligase (4CL), such that when the nucleotide sequence is 
expressed in the plant, the characteristic of the plant is 
altered, wherein the characteristic is selected from the group 
consisting of altered growth, altered lignin content, 
increased or decreased coniferyl and sinapyl alcohol units in 60 
the lignin structure, increased or decreased disease 
resistance, altered cellulose content and combinations 
thereof compared to a control plant that is not transformed 
with the nucleotide sequence.
2. A plant having a characteristic genetically altered 65 
through incorporation into the genome of the plant a nucle­
otide sequence encoding p-coumarate Co-enzyme A ligase
(4CL), such that when the nucleotide sequence is expressed 
in the plant, the characteristic of the plant is altered, wherein 
the characteristic is selected from the group consisting of 
altered growth, altered lignin content, increased or decreased 
coniferyl and sinapyl alcohol units in the lignin structure, 
increased or decreased disease resistance, altered cellulose 
content and combinations thereof compared to a control 
plant that is not transformed with the nucleotide sequence.
3. The method as set forth in claim 1 wherein the 
nucleotide sequence is in the anti-sense orientation.
4. The method as set forth in claim 1 wherein the 
nucleotide sequence is in the sense orientation.
5. The method as set forth in claim 1 wherein the 4CL 
comprises an AMP-binding region conserved in all 4CL 
enzymes in the lignin biosynthetic pathway.
6 . The method as set forth in claim 1 wherein the 
nucleotide sequence comprises:
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(a) the nucleotide sequence of SEO ID NO:l;
(b) a nucleotide sequence having at least about 60% 
sequence identity to SEQ ID NO:l; or
(c) a nucleotide sequence that is complementary to (a) or 
(b).
7. The method as set forth in claim 1 wherein the 
nucleotide sequence has at least 60% identity to the endog­
enous 4CL gene.
8. The method as set forth in claim 1 wherein the 
incorporating is by plant transformation.
9. The method as set forth in claim 8 wherein the 
transformation is Agrobacterium-mediated transformation.
10. The method as set forth in claim 1 wherein the 
nucleotide sequence is a cDNA.
11. The method as set forth in claim 1 wherein the 
nucleotide sequence is operably linked to the CaMV 35S 
promoter.
12. The method as set forth in claim 1 wherein the plant 
is a tree.
13. The method as set forth in claim 12 wherein the tree 
is an angiosperm.
14. The method as set forth in claim 12 wherein the tree 
is a gymnosperm.
15. The method as set forth in claim 1 wherein the altered 
characteristic is accelerated growth and wherein the accel­
erated growth is manifested as an increase in the average 
internode length.
16. The method as set forth in claim 1 wherein the altered 
characteristic is accelerated growth and wherein the accel­
erated growth is manifested as an increase in plant height.
17. The method as set forth in claim 1 wherein the altered 
characteristic is accelerated growth and wherein the accel­
erated growth is manifested as an increase in plant diameter.
18. The method as set forth in claim 1 wherein the altered 
characteristic is increased disease resistance and wherein the 
increased disease resistance is increased fungal pathogen 
resistance.
19. The method as set forth in claim 1 wherein the 
nucleotide sequence is contained in a binary vector.
20. The plant as set forth in claim 2 wherein the nucleotide 
sequence is in the anti-sense orientation.
21. The plant as set forth in claim 2 wherein the nucleotide 
sequence is in the sense orientation.
22. The plant as set forth in claim 2 wherein the 4CL 
comprises an AMP-binding region conserved in all 4CL 
enzymes in the lignin biosynthetic pathway.
23. The plant as set forth in claim 2 wherein the nucleotide 
sequence comprises:
(a) the nucleotide sequence of SEO ID NO:l;
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(b) a nucleotide sequence having at least about 60% 
sequence identity to SEQ ID NO:l; or
(c) a nucleotide sequence that is complementary to (a) or 
(b).
24. The plant as set forth in claim 2 wherein the nucleotide 
sequence has at least 60% identity to the endogenous 4CL 
gene.
25. The plant as set forth in claim 2 wherein the nucleotide 
sequence is incorporated into the genome of the plant by 
transformation.
26. The plant as set forth in claim 25 wherein the 
transformation is Agrobacterium-mediated transformation.
27. The plant as set forth in claim 2 wherein the nucleotide 
sequence is a cDNA.
28. The plant as set forth in claim 2 wherein the nucleotide 
sequence is operably linked to the CaMV 35S promoter.
29. The plant as set forth in claim 2 wherein the plant is 
a tree.
30. The plant as set forth in claim 29 wherein the tree is 
an angiosperm.
31. The plant as set forth in claim 29 wherein the tree is 
a gymnosperm.
32. The plant as set forth in claim 2 wherein the altered 
characteristic is accelerated growth and wherein the accel­
erated growth is manifested as an increase in the average 
internode length.
33. The plant as set forth in claim 2 wherein the altered 
characteristic is accelerated growth and wherein the accel­
erated growth is manifested as an increase in plant height.
34. The plant as set forth in claim 2 wherein the altered 
characteristic is accelerated growth and wherein the accel­
erated growth is manifested as an increase in plant diameter.
35. The plant as set forth in claim 2 wherein the altered 
characteristic is increased disease resistance and wherein the 
increased disease resistance is increased fungal pathogen 
resistance.
36. The plant as set forth in claim 2 wherein the nucleotide 
sequence is contained in a binary vector.
37. The method as set forth in claim 1 wherein the 
nucleotide sequence encodes a polypeptide comprising the 
amino acid sequence of SEQ ID NO:2, or a polypeptide 
comprising an AMP-binding region conserved in all 4CL 
enzymes in the lignin biosynthetic pathway.
38. The plant as set forth in claim 2 wherein the nucleotide 
sequence encodes a polypeptide comprising the amino acid 
sequence of SEQ ID NO:2, or a polypeptide comprising an 
AMP-binding region conserved in all 4CL enzymes in the 
lignin biosynthetic pathway.
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